Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart speakers join the care team: can voice tech help older adults manage chronic illness?

NCT ID NCT07836114

Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers at Emory University are testing a nurse-led program that blends home visits and telehealth coaching with voice-controlled smart speakers and smartwatches. The study enrolls about 50 adults aged 65 and older who live independently, have two or more chronic conditions, and have mild cognitive impairment. The program aims to support self-care for chronic illness, and the team also examines what nursing staff and clinic resources would be needed to offer it in regular outpatient care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A nurse-led hybrid care program that combines home visits and telehealth coaching with personalized smart speakers and smartwatches
What this could lead to
If it works, this could give older adults with mild cognitive impairment a practical way to manage chronic conditions at home, and it could show clinics what staffing and resources such a program needs.
What could go wrong
The study is small, with about 50 participants, and it measures self-care confidence and technology comfort rather than hard health outcomes like hospital visits. Voice technology may not suit everyone, and results from this group may not apply to older adults with more advanced memory problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 years or older * Two or more chronic conditions * Mild cognitive impairment, defined as a Montreal Cognitive Assessment Blind (MoCA-Blind) score of 13 to 17, with no diagnosis of Alzheimer's disease or a related dementia * Living independently in a community-based setting (not residing in a nursing home or in assisted living with skilled nursing support) * Able to speak, read, and understand English * Able to provide informed consent for themselves, as confirmed at the time of consent * Home environment able to accommodate the study devices, including electrical power and a suitable location for an Echo Show * Willing and able to engage in a technology-based intervention, as indicated by a Yes response to an engagement-readiness item administered during screening Exclusion Criteria: * Diagnosis of Alzheimer's disease or a related dementia * Adults unable to consent for themselves * Individuals who are not able to clearly understand English * Severe uncorrected hearing or vision impairment that would prevent interaction with a voice-activated device with a screen * Planned relocation or absence from the home for an extended period during the 12-week study period * Concurrent enrollment in another intervention study addressing chronic disease self-management * Any medical, psychiatric, or social circumstance that, in the judgment of the study team, would prevent safe participation or completion of study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease Mild cognitive impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Metro Atlanta Area

    Atlanta, Georgia, 30030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.